Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H L Halliday

Showing results (41-50 of 172) with videos related to

Pageof 18
Sort By:
The Cochrane Database of Systematic Reviews|May 5, 2000
Delayed (>3 weeks) postnatal corticosteroids for chronic lung disease in preterm infantsH L Halliday, R A Ehrenkranz
The Cochrane Database of Systematic Reviews|May 5, 2000
Early postnatal (<96 hours) corticosteroids for preventing chronic lung disease in preterm infantsH L Halliday, R A Ehrenkranz
Irish Medical Journal|April 24, 1976
Common respiratory problems of the newbornH L Halliday, B G McClure
The Cochrane Database of Systematic Reviews|May 2, 2001
Moderately early (7-14 days) postnatal corticosteroids for preventing chronic lung disease in preterm infantsH L Halliday, R A Ehrenkranz
Paediatric Drugs|August 11, 2000
Current perspectives on the drug treatment of neonatal respiratory distress syndromeD G Sweet, H L Halliday
Drug Safety|June 1, 2000
A risk-benefit assessment of drugs used for neonatal chronic lung diseaseD G Sweet, H L Halliday
Archives of Disease in Childhood. Fetal and Neonatal Edition|January 1, 1995
Prediction of chronic lung disease (CLD)J D Corcoran, H L Halliday
The Cochrane Database of Systematic Reviews|May 5, 2000
Moderately early (7-14 days) postnatal corticosteroids for preventing chronic lung disease in preterm infantsH L Halliday, R A Ehrenkranz
Early Human Development|February 27, 2001
The present status of exogenous surfactant for the newbornA E Curley, H L Halliday
British Medical Journal|December 13, 1975
Letter: Use of clonazepam in epilepsyH L Halliday, J F Glasgow
Pageof 18

Showing results (41-50 of 172) with videos related to

Sort By:
Pageof 18
The Cochrane Database of Systematic Reviews|May 5, 2000
Delayed (>3 weeks) postnatal corticosteroids for chronic lung disease in preterm infantsH L Halliday, R A Ehrenkranz
The Cochrane Database of Systematic Reviews|May 5, 2000
Early postnatal (<96 hours) corticosteroids for preventing chronic lung disease in preterm infantsH L Halliday, R A Ehrenkranz
Irish Medical Journal|April 24, 1976
Common respiratory problems of the newbornH L Halliday, B G McClure
The Cochrane Database of Systematic Reviews|May 2, 2001
Moderately early (7-14 days) postnatal corticosteroids for preventing chronic lung disease in preterm infantsH L Halliday, R A Ehrenkranz
Paediatric Drugs|August 11, 2000
Current perspectives on the drug treatment of neonatal respiratory distress syndromeD G Sweet, H L Halliday
Drug Safety|June 1, 2000
A risk-benefit assessment of drugs used for neonatal chronic lung diseaseD G Sweet, H L Halliday
Archives of Disease in Childhood. Fetal and Neonatal Edition|January 1, 1995
Prediction of chronic lung disease (CLD)J D Corcoran, H L Halliday
The Cochrane Database of Systematic Reviews|May 5, 2000
Moderately early (7-14 days) postnatal corticosteroids for preventing chronic lung disease in preterm infantsH L Halliday, R A Ehrenkranz
Early Human Development|February 27, 2001
The present status of exogenous surfactant for the newbornA E Curley, H L Halliday
British Medical Journal|December 13, 1975
Letter: Use of clonazepam in epilepsyH L Halliday, J F Glasgow
Pageof 18